Spicing up prostate cancer theranostics
Ludovica Wilhelmina Maria van Kalmthout · Utrecht University Repository (Utrecht University) · 2020
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Utrecht University Repository (Utrecht University) · Utrecht University · dissertation · 2020
Abstract
After the publication of this meta-analysis, Luiting et al. (2020) also reviewed diagnostic performance of [ 68 Ga]Ga-PSMA PET/CT for lymph node detection in primary staging in men with PCa.43 Eleven studies were included in this review: two prospective studies (n = 63 patients) and nine retrospective studies (n = 696 patients).In all studies, histopathology was referred to as gold standard.Patient-based sensitivity and specificity ranges of respectively 64-100% and 90-95% were found in the prospective studies.Lesion-based sensitivity and specificity ranges were respectively 50-58% and 96-100%.In the retrospective studies, the sensitivity and specificity range was respectively 33.3-100% and 80-100%.With regard to the lesion-based analysis, they found a sensitivity and specificity range of 24.4-96.1% and 98.6-100%, respectively.Especially sensitivity was lower in comparison with the previously discussed meta-analysis by Hope et al.
42 , who included significantly less studies.This reflects that definite diagnostic value of [ 68 Ga]Ga-PSMA PET/CT in primary staging of PCa still needs to be determined by future reviews and meta-analyses including well-designed prospective studies.With regard to diagnostic performance of [ 18 F]F-labelled PSMA tracers in primary staging of PCa however, only a small number of studies has been published.Gorin et al. prospectively evaluated diagnostic performance of preoperative [ 18 F]F-DCFPyL PET/CT in 25 men with high risk PCa being eligible for prostatectomy and ePLND.44 When compared to histopathology findings, patient-based sensitivity and specificity was respectively 71.4% (95% CI 29.0-96.3%)and 88.9% (95% CI 65.3-98.6%).Lesion-based sensitivity and specificity was 66.7% (95% CI 29.9-92.5%)and 97.7% (95% CI 80.1-98.5%),respectively.At present, the diagnostic performance of [ 18 F]F-DCFPyL and [ 18 F] F-PSMA-1007 in the setting of initial staging of PCa with histopathology reference are currently under investigation in prospective trials conducted at the Amsterdam UMC, location VUmc (the SALT-study; NL6754), and the Canisius Wilhelmina Ziekenhuis in Nijmegen (the MINT-study; NL7428).
Open the resolved locator · 10.33540/334
Metadata licence: OpenAlex metadata (CC0)